Cargando…
Epigenetic dysregulation in glioma
Given that treatment options for patients with glioblastoma are limited, much effort has been made to clarify the underlying mechanisms of gliomagenesis. Recent genome-wide genomic and epigenomic analyses have revealed that mutations in epigenetic modifiers occur frequently in gliomas and that dysre...
Autores principales: | Kondo, Yutaka, Katsushima, Keisuke, Ohka, Fumiharu, Natsume, Atsushi, Shinjo, Keiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317798/ https://www.ncbi.nlm.nih.gov/pubmed/24843883 http://dx.doi.org/10.1111/cas.12379 |
Ejemplares similares
-
Long non‐coding RNAs as an epigenetic regulator in human cancers
por: Kondo, Yutaka, et al.
Publicado: (2017) -
Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment
por: Katsushima, Keisuke, et al.
Publicado: (2016) -
Non-coding RNAs as epigenetic regulator of glioma stem-like cell differentiation
por: Katsushima, Keisuke, et al.
Publicado: (2014) -
Current Trends in Targeted Therapies for Glioblastoma Multiforme
por: Ohka, Fumiharu, et al.
Publicado: (2012) -
H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutant
por: Maeda, Sachi, et al.
Publicado: (2020)